NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1030230122

Registered date:08/06/2023

A Study on Optimizing Setup Margins in Carbon Ion Radiotherapy

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedLung cancer, prostate cancer, liver cancer, breast cancer, kidney cancer
Date of first enrollment01/06/2023
Target sample size750
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeSystematically organize the deviations and trends in marker positions for each treated organ, pre-treatment, and irradiated body position, and determine the setup margin for each condition.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
Gender
Include criteriaPatients treated with Carbon-ion radiotherapy for lung, prostate, liver, breast, and kidney at QST Hospital between March 2020 and February 2023 after gold marker insertion are eligible.
Exclude criteria1. Patients whose gold marker location information is not stored. 2. Patients who have requested to refuse the use of their information for this study.

Related Information

Contact

Public contact
Name Noriyuki Okonogi
Address 4-9-1 Anagawa, Inage-ku, Chiba City, Chiba Chiba Japan 263-8555
Telephone +81-43-206-3306
E-mail okonogi.noriyuki@qst.go.jp
Affiliation National Institutes for Quantum Science and Technology
Scientific contact
Name Noriyuki Okonogi
Address 4-9-1 Anagawa, Inage-ku, Chiba City, Chiba Chiba Japan 263-8555
Telephone +81-43-206-3306
E-mail okonogi.noriyuki@qst.go.jp
Affiliation National Institutes for Quantum Science and Technology